EP0552297A4 - - Google Patents

Info

Publication number
EP0552297A4
EP0552297A4 EP19910920333 EP91920333A EP0552297A4 EP 0552297 A4 EP0552297 A4 EP 0552297A4 EP 19910920333 EP19910920333 EP 19910920333 EP 91920333 A EP91920333 A EP 91920333A EP 0552297 A4 EP0552297 A4 EP 0552297A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910920333
Other versions
EP0552297A1 (en
Inventor
Mahlon F. Miller
Richard R. Lesniewski
David A. Peterson
Warren Hugh Bryce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of EP0552297A1 publication Critical patent/EP0552297A1/en
Publication of EP0552297A4 publication Critical patent/EP0552297A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP91920333A 1990-10-12 1991-10-09 Hepatitis c virus antibody Withdrawn EP0552297A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59681190A 1990-10-12 1990-10-12
US596811 1990-10-12

Publications (2)

Publication Number Publication Date
EP0552297A1 EP0552297A1 (en) 1993-07-28
EP0552297A4 true EP0552297A4 (ja) 1994-02-09

Family

ID=24388816

Family Applications (1)

Application Number Title Priority Date Filing Date
EP91920333A Withdrawn EP0552297A1 (en) 1990-10-12 1991-10-09 Hepatitis c virus antibody

Country Status (7)

Country Link
EP (1) EP0552297A1 (ja)
JP (1) JPH06502075A (ja)
KR (1) KR930702506A (ja)
AU (1) AU663064B2 (ja)
CA (1) CA2093919A1 (ja)
TW (1) TW216797B (ja)
WO (1) WO1992007001A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0556320T3 (da) * 1990-11-07 1999-10-18 Abbott Lab Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
ES2377968T3 (es) 2003-04-01 2012-04-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Anticuerpos dirigidos contra el complejo E1E2 del virus de la hepatitis C y composiciones farmacéuticas
NZ579706A (en) 2007-02-21 2012-03-30 Univ Massachusetts Human antibodues against hepatitis C virus (HCV) E2 protein and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU216017B (hu) * 1987-11-18 1999-04-28 Chiron Corp. Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
AU632271B2 (en) * 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO1992007001A1 (en) 1992-04-30
AU663064B2 (en) 1995-09-28
CA2093919A1 (en) 1992-04-13
JPH06502075A (ja) 1994-03-10
AU8945791A (en) 1992-05-20
KR930702506A (ko) 1993-09-09
TW216797B (ja) 1993-12-01
EP0552297A1 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
DE4190992T (ja)
DE4190941T (ja)
EP0486635A4 (ja)
DE4192071T (ja)
FR2658574B1 (ja)
DE4092522T (ja)
EP0507951A4 (ja)
FR2660741B1 (ja)
DE4191772T (ja)
DE4192508T (ja)
FR2663250B1 (ja)
DE4190843T (ja)
FR2657929B1 (ja)
DE4190457T1 (ja)
FR2667191B1 (ja)
TW216797B (ja)
DE4191099T (ja)
FR2668443B3 (ja)
JPH0490727U (ja)
FR2660607B1 (ja)
IN175178B (ja)
ECSM90500U (ja)
ECSM90476U (ja)
ECSM90432U (ja)
ECSM90481U (ja)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930302

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: C12P 21/08

A4 Supplementary search report drawn up and despatched

Effective date: 19931220

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19950731

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19951212